AbbVie falls after trimming 2026 profit forecast
BUZZ-AbbVie falls after trimming 2026 profit forecast ** Shares of drugmaker AbbVie ABBV.N fall 4.4% to $246 premarket
** Co trims 2026 profit forecast between $13.87 and $14.07, compared with its prior range of $13.91 to $14.11
** Analysts expects adjusted profit to be $14.08 per share - LSEG data
** Posts Q2 adjusted profit of $3.65 per share vs analysts' estimate of $3.60 per share
** Reports Q2 revenue of $16.99 billion vs estimates of $16.77 billion
** As of last close, stock up 12.7% YTD
(Reporting by Siddhi Mahatole)
Recent news on AbbVie
See all newsBrief: Abbvie Reaches Agreement With The Pan-Canadian Pharmaceutical Alliance (Pcpa) For Elahere® In Platinum-Resistant Ovarian Cancer
Eli Lilly hits record high as healthcare stocks rally
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Brief: Abbvie Says Risankizumab In Ulcerative Colitis Shows Clinical Remission Rates Of 54.0%-73.1% At Week 96